MetaCap

Cumberland Pharmaceuticals (CPIX) vs Journey Medical (DERM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cumberland Pharmaceuticals (CPIX) has outperformed Journey Medical (DERM) over the past year, gaining 193.5% versus a loss of 55.8%. Over five years, CPIX leads with a +161.9% price change compared with -61.1% for DERM. Journey Medical is the larger company by market cap ($93.2 million vs $87.6 million), about 1.1 times the size, while Cumberland Pharmaceuticals is growing revenue faster (+17.6% vs +10.2%).

Cumberland Pharmaceuticals converts more of its revenue into profit, with a net margin of -6.4% versus -18.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CPIX+193.47%DERM-55.76%
+371%+147%-76%
Nov 21, 20251 yearNov 20, 2026
CPIX+134.54%DERM-62.46%
+257%+77%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CPIX versus DERM key metrics
MetricCPIXDERM
Share price$5.84$3.30
Market cap$87.57M$93.16M
1-day change-7.30%-7.04%
YTD return+46.73%-57.20%
1-year return+193.47%-55.76%
5-year return+161.88%-61.13%
Forward P/E41.71—
EPS (TTM)$-0.57$-0.18
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.52M$61.86M
Revenue growth (YoY)+17.57%+10.20%
Net income (latest FY)$-2.84M$-11.43M
Gross margin85.02%66.17%
Operating margin-6.27%-13.21%
Net margin-6.37%-18.48%
52-week high$9.28$9.56
52-week low$2.00$3.21
Distance from 52-week high-37.07%-65.46%
Analyst consensus—strong_buy
Avg. price target upside—+286.36%
Average volume114.52K190.39K
Shares outstanding15.00M22.23M
Employees8858
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CPIX has outperformed DERM by 249.2 percentage points over the past year.
  • Cumberland Pharmaceuticals is more profitable, keeping -6.4 cents of every revenue dollar as net income versus -18.5 cents for Journey Medical.
  • Cumberland Pharmaceuticals grew revenue faster in its latest fiscal year (+17.57% vs +10.20%).

About Cumberland Pharmaceuticals

CPIX stock →

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.

Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees

About Journey Medical

DERM stock →

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.

Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees

CPIX vs DERM FAQ

Which is bigger, Cumberland Pharmaceuticals or Journey Medical?

Journey Medical (DERM) is larger, with a market capitalization of $93.16M compared with $87.57M for Cumberland Pharmaceuticals (CPIX).

Which stock has performed better over the past year, CPIX or DERM?

CPIX returned +193.47% over the past 12 months, compared with -55.76% for DERM (price return, excluding dividends). Past performance does not predict future results.

Are Cumberland Pharmaceuticals and Journey Medical in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons